US 9228014
Antibodies capable of blocking the interaction between CD48 and a CD48 receptor
granted A61KA61K2039/505A61P
Quick answer
US patent 9228014 (Antibodies capable of blocking the interaction between CD48 and a CD48 receptor) held by REGENERON PHARMACEUTICALS, INC. expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2039/505, A61P, A61P1/00, A61P1/04